Not Rated
|
Fund Size
(0.54% of Investment in Category)
|
Expense Ratio
(0.89% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 31-Oct-25 | 9952.60 | -0.47% | - | -0.79% | 73/231 |
| 1 Month | 07-Oct-25 | 10021.20 | 0.21% | - | 0.87% | 151/227 |
| 3 Month | 07-Aug-25 | 10147.20 | 1.47% | - | 3.98% | 199/224 |
| 6 Month | 07-May-25 | 10674.00 | 6.74% | - | 9.35% | 148/213 |
| YTD | 01-Jan-25 | 9819.90 | -1.80% | - | 4.42% | 157/201 |
| 1 Year | 07-Nov-24 | 10141.10 | 1.41% | 1.41% | 3.56% | 118/187 |
| 2 Year | 07-Nov-23 | 15325.50 | 53.25% | 23.76% | 20.54% | 35/141 |
| 3 Year | 07-Nov-22 | 18165.10 | 81.65% | 21.99% | 19.90% | 37/117 |
| 5 Year | 06-Nov-20 | 23750.50 | 137.50% | 18.86% | 22.81% | 65/93 |
| Since Inception | 02-Jul-18 | 42746.10 | 327.46% | 21.83% | 13.90% | 25/199 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 07-Nov-24 | 12000 | 12437.27 | 3.64 % | 6.79 % |
| 2 Year | 07-Nov-23 | 24000 | 27366.31 | 14.03 % | 13.14 % |
| 3 Year | 07-Nov-22 | 36000 | 48860.99 | 35.72 % | 20.84 % |
| 5 Year | 06-Nov-20 | 60000 | 94970.11 | 58.28 % | 18.4 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 3195.6 | 11.57% | 0.65% | 12.5% (Apr 2025) | 10.74% (Jul 2025) | 20.04 L | 90.00 k |
| Divis Laboratories Ltd. | Pharmaceuticals | 2143.1 | 7.76% | -0.39% | 8.53% (Jun 2025) | 4.96% (Oct 2024) | 3.77 L | 5.00 k |
| Glenmark Pharmaceuticals Ltd. | Pharmaceuticals | 1925.5 | 6.97% | 0.19% | 7.24% (Jul 2025) | 5.22% (Apr 2025) | 9.86 L | 0.00 |
| Apollo Hospitals Enterprises Ltd. | Hospital | 1719.2 | 6.23% | -0.09% | 6.37% (Jun 2025) | 4.82% (Dec 2024) | 2.32 L | 0.00 |
| Cipla Ltd. | Pharmaceuticals | 1665.8 | 6.03% | -0.27% | 7.6% (Feb 2025) | 6.03% (Sep 2025) | 11.08 L | 0.00 |
| Lupin Ltd. | Pharmaceuticals | 1393.7 | 5.05% | 0.10% | 6.37% (Apr 2025) | 4.94% (Jul 2025) | 7.29 L | 0.00 |
| Aurobindo Pharma Ltd. | Pharmaceuticals | 1195.1 | 4.33% | -1.69% | 8.05% (Oct 2024) | 4.33% (Sep 2025) | 11.03 L | -5.33 L |
| Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 1158.2 | 4.19% | -0.07% | 6.38% (Dec 2024) | 4.13% (Jul 2025) | 9.46 L | 0.00 |
| Fortis Healthcare Ltd. | Hospital | 1157.1 | 4.19% | 0.30% | 4.19% (Sep 2025) | 2.12% (Jan 2025) | 11.93 L | 0.00 |
| Krishna Institute of Medical Sciences Ltd. | Hospital | 1033.2 | 3.74% | -0.08% | 4.32% (Nov 2024) | 3.57% (Feb 2025) | 14.76 L | 0.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 0.25% |
| MF Units | MF Units | 0.01% |
| Net Receivables | Net Receivables | -0.15% |
Ratios calculated on daily returns for last 3 years (Updated as on 31st October, 2025)
Out of 51 mutual fund schemes offered by this AMC, 3 is/are ranked 5 * , 4 is/are ranked 4 * , 4 is/are ranked 3 * , 4 is/are ranked 2 * , and 36 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Mirae Asset Large & Midcap Fund - Direct Plan - Growth | 3 | 40821.90 | 2.11 | 5.77 | 11.31 | 6.47 | 17.89 |
| Mirae Asset Large Cap Fund - Direct Plan - Growth | 3 | 39615.50 | 1.57 | 3.88 | 7.09 | 6.61 | 13.72 |
| Mirae Asset ELSS Tax Saver Fund - Direct Plan - Growth | 4 | 25910.64 | 2.00 | 5.05 | 9.91 | 7.35 | 18.10 |
| Mirae Asset Midcap Fund - Direct Plan - Growth | 3 | 17194.25 | 2.28 | 6.59 | 16.93 | 7.78 | 21.22 |
| Mirae Asset Liquid Fund - Direct Plan - Growth | 4 | 11367.77 | 0.48 | 1.46 | 3.05 | 6.76 | 7.09 |
| Mirae Asset Aggressive Hybrid Fund - Direct Plan - Growth | 3 | 9128.00 | 1.34 | 3.47 | 7.33 | 7.20 | 14.79 |
| Mirae Asset Focused Fund - Direct Plan - Growth | 2 | 7769.11 | 0.40 | 2.89 | 7.24 | 2.84 | 12.69 |
| Mirae Asset Great Consumer Fund - Direct Plan - Growth | NA | 4632.32 | -0.24 | 3.48 | 8.46 | 3.89 | 18.09 |
| Mirae Asset Multicap Fund - Direct Plan - Growth | NA | 4126.15 | 1.29 | 4.53 | 11.97 | 6.30 | 0.00 |
| Mirae Asset Flexi Cap Fund - Direct Plan - Growth | NA | 3107.47 | 2.48 | 5.05 | 11.26 | 8.30 | 0.00 |